Put Options

17 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2022

Sep 21, 2023

SELL
$71.48 - $86.85 $1.54 Million - $1.87 Million
-21,500 Reduced 68.25%
10,000 $828,000
Q2 2022

Aug 15, 2022

SELL
$71.48 - $86.85 $1.54 Million - $1.87 Million
-21,500 Reduced 68.25%
10,000 $829,000
Q3 2021

Sep 21, 2023

BUY
$74.77 - $85.47 $1.23 Million - $1.41 Million
16,500 Added 110.0%
31,500 $2.43 Million
Q3 2021

Nov 15, 2021

BUY
$74.77 - $85.47 $1.23 Million - $1.41 Million
16,500 Added 110.0%
31,500 $2.44 Million
Q2 2021

Aug 20, 2021

SELL
$75.51 - $84.79 $112 Million - $126 Million
-1,485,000 Reduced 99.0%
15,000 $1.25 Million
Q2 2021

Aug 16, 2021

BUY
$75.51 - $84.79 $112 Million - $126 Million
1,485,000 Added 9900.0%
1,500,000 $1.25 Million
Q1 2021

Sep 21, 2023

SELL
$74.73 - $90.69 $732,354 - $888,762
-9,800 Reduced 39.52%
15,000 $1.13 Million
Q1 2021

May 14, 2021

SELL
$74.73 - $90.69 $732,354 - $888,762
-9,800 Reduced 39.52%
15,000 $1.13 Million
Q4 2020

Sep 21, 2023

BUY
$72.61 - $90.2 $1.8 Million - $2.24 Million
24,800 New
24,800 $2.17 Million
Q4 2020

Feb 16, 2021

BUY
$72.61 - $90.2 $1.09 Million - $1.35 Million
15,000 Added 153.06%
24,800 $2.18 Million
Q3 2020

Nov 13, 2020

BUY
$71.87 - $131.03 $323,415 - $589,635
4,500 Added 84.91%
9,800 $746,000
Q1 2020

May 15, 2020

SELL
$71.37 - $96.85 $5.03 Million - $6.83 Million
-70,500 Reduced 93.01%
5,300 $448,000
Q3 2019

Nov 13, 2019

BUY
$67.4 - $85.11 $4.28 Million - $5.4 Million
63,500 Added 516.26%
75,800 $5.11 Million
Q2 2019

Aug 14, 2019

BUY
$80.35 - $93.9 $731,185 - $854,490
9,100 Added 284.38%
12,300 $1.05 Million
Q1 2019

May 15, 2019

SELL
$84.2 - $98.62 $1.18 Million - $1.38 Million
-14,000 Reduced 81.4%
3,200 $284,000
Q4 2018

Feb 14, 2019

SELL
$80.14 - $106.07 $2.63 Million - $3.48 Million
-32,800 Reduced 65.6%
17,200 $1.47 Million
Q4 2017

Feb 14, 2018

BUY
$80.76 - $95.13 $4.04 Million - $4.76 Million
50,000
50,000 $4.46 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.